XML 42 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation Plans
6 Months Ended
Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Plans

(6) Stock-Based Compensation Plans. As more fully described in Note 7 to the Company’s notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended September 30, 2013, the Company’s stock-based compensation plan permits the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, and stock awards. The number of common shares available for future issuance was 486,590 at March 31, 2014.

 

The Company recorded the following stock compensation expense in its consolidated statements of income (in thousands):

 

    Three Months ended   Six Months ended
    March 31,   March 31,
    2014   2013   2014   2013
Stock option grants   $ 93       89       262       219  
Annual director stock award     698       507       698       507  
    $ 791       596       960       726  

 

A summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

 

            Weighted       Weighted       Weighted  
    Number       Average       Average       Average  
    of       Exercise       Remaining       Grant Date  
Options   Shares       Price       Term (yrs)       Fair Value  
                               
Outstanding at                              
 October 1, 2013   414,590     $ 20.40       4.2     $ 3,668  
  Granted   31,790     $ 41.39             $ 545  
  Exercised   55,699     $ 12.01             $ 335  
Outstanding at                              
 March 31, 2014   390,681     $ 23.30       4.7     $ 3,878  
Exercisable at                              
 March 31, 2014   303,527     $ 21.39       3.6     $ 2,745  
Vested during                              
 six months ended                              
 March 31, 2014   28,348                     $ 322  

 

The aggregate intrinsic value of exercisable in-the-money options was $4,489,000 and the aggregate intrinsic value of all outstanding in-the-money options was $5,151,000 based on the market closing price of $36.05 on March 31, 2014 less exercise prices. Gains of $1,485,000 were realized by option holders during the six months ended March 31, 2014. The realized tax benefit from options exercised for the six months ended March 31, 2014 was $575,000. The unrecognized compensation cost of options granted but not yet vested as of March 31, 2014 was $994,000, which is expected to be recognized over a weighted-average period of 3.6 years.